new low-molecular-weight heparin called Innohep
You'll see a new low-molecular-weight heparin called Innohep.It will compete with Lovenox...for treating deep vein thrombosis (DVT) with or without pulmonary embolism (PE).
Innohep (tinzaparin) and Lovenox are the only low-molecular-weight heparins that are approved to TREAT blood clots...the others are only approved for prevention.
Both Innohep and Lovenox cost about the same.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote